FDA Adds New Gastrointestinal Side Effect Warning to Ozempic Label The U.S. Food and Drug Administration (FDA) has recently revised the labeling requirements for Ozempic, a medication commonly prescribed to manage type 2 diabetes. The updated label now includes a warning regarding potential gastrointestinal side effects that patients may experience while taking this drug. Ozempic … Read more
FDA Enhances Safety Information for Ozempic with New Gastrointestinal Side Effect Warning March 15, 2022 The FDA’s Latest Update The Food and Drug Administration (FDA) has recently announced an important update to the label of the diabetes medication Ozempic (semaglutide). The agency is adding a new warning about potential gastrointestinal side effects to the label … Read more
FDA Adds New Gastrointestinal Side Effect Warning to Ozempic Label The Food and Drug Administration (FDA) has recently issued an important update to the label for the diabetes drug, Ozempic (semaglutide), to include a new warning regarding potential gastrointestinal side effects. What is Ozempic? Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for the … Read more